Search

Your search keyword '"Sommet A"' showing total 97 results

Search Constraints

Start Over You searched for: Author "Sommet A" Remove constraint Author: "Sommet A" Region france Remove constraint Region: france
97 results on '"Sommet A"'

Search Results

1. Cooperative Learning Reduces the Gender Gap in Perceived Social Competences: A Large-Scale Nationwide Longitudinal Experiment

2. Meteorological factors and rhegmatogenous retinal detachment in metropolitan France.

3. Factors associated with adverse outcome among children with sickle cell disease admitted to the pediatric intensive care unit: an observational cohort.

4. To Confirm or to Conform? Performance Goals as a Regulator of Conflict with More-Competent Others

5. Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions.

6. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease‐specific treatments: a French nationwide cohort study.

7. Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19.

8. Outcome of patients hospitalized for COVID‐19 and exposure to angiotensin‐converting enzyme inhibitors and angiotensin‐receptor blockers in France: results of the ACE‐CoV study.

9. Does substitution of brand name medications by generics differ between pharmacotherapeutic classes? A population-based cohort study in France.

10. Children with chronic health disorders travelling to the tropics: a prospective observational study.

11. When should clinicians suspect group A streptococcus empyema in children? A multicentre case-control study in French tertiary care centres.

12. Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database.

13. Healthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis: a cohort analysis in the French insurance database.

14. Morbidity among child travellers with sickle-cell disease visiting tropical areas: an observational study in a French tertiary care centre.

15. Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions: a PharmacoVigilance study in France.

16. Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study.

17. Trends of reporting of 'serious' vs. 'non-serious' adverse drug reactions over time: a study in the French PharmacoVigilance Database.

18. The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France.

19. Antibiotics for nasopharyngitis are associated with a lower risk of office-based physician visit for acute otitis media within 14 days for 3- to 6-year-old children.

20. Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).

21. Coxibs: evolution of prescription's behaviour in France.

22. Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals.

23. Mortality rates among patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: comment on the article by Simard et al.

24. Mortality and Antipsychotic Drug Use in Elderly Patients With Parkinson Disease in Nursing Homes.

25. Use of the French National Health Data System (SNDS) in pharmacoepidemiology: A systematic review in its maturation phase.

26. Teaching pharmacovigilance to French medical students during the COVID-19 pandemic: Interest of distance learning clinical reasoning sessions.

27. Amantadine use in the French prospective NS-Park cohort.

28. The economic burden of asthma prior to death: a nationwide descriptive study.

29. Deleterious association between proton pump inhibitor and protein kinase inhibitor exposure and survival for patients with lung cancer: A nationwide cohort study.

31. Eltrombopag in adult patients with immune thrombocytopenia in the real-world in France, including off-label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study.

32. Healthcare resource consumption prior to asthma-related death: a nationwide descriptive study.

33. Tramadol-induced hypoglycemia: A pharmacovigilance study.

34. A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study.

36. The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial.

37. Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database.

38. Clinical characteristics and outcome of hospitalized patients with SARS-CoV-2 infection at Toulouse University hospital (France). Results from the Covid-clinic-Toul cohort.

39. No increased risk of cataract in adult patients with primary immune thrombocytopenia treated with eltrombopag. A French nationwide nested case-control study.

40. Efficacy of teicoplanin monotherapy following initial standard therapy in Enterococcus faecalis infective endocarditis: a retrospective cohort study.

41. Enhanced culture recovery of Campylobacter with modified Cary-Blair medium: A practical field experience.

42. Parenteral anticoagulants use in general practice: a cross-sectional study in South Western France.

43. More on the "Triple Whammy": antihypertensive drugs, non-steroidal anti-inflammatory agents and acute kidney injury - a case/non-case study in the French pharmacovigilance database.

44. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database.

45. [Use of Nadis(®) software to improve adverse drug reaction reporting of antiretroviral drugs: experience in south west of France (midi-pyrénées)].

46. Impact of polypharmacy on occurrence of delirium in elderly emergency patients.

47. [Generic substitution in primary care in 2011: differences according to pharmacological classes?].

48. Use of drugs, tobacco, alcohol and illicit substances in a French student population.

49. Statin-induced lupus: a case/non-case study in a nationwide pharmacovigilance database.

50. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006.

Catalog

Books, media, physical & digital resources